We are live on ! Find out more
RC

Roundview Capital Portfolio holdings

AUM $1.61B
1-Year Est. Return 16.92%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+16.92%
3 Year Est. Return
+63.17%
5 Year Est. Return
+78.22%
10 Year Est. Return
+279.65%
AUM
$387M
AUM Growth
+$37.6M
Cap. Flow
+$17.1M
Cap. Flow %
4.41%
Top 10 Hldgs %
25.66%
Holding
238
New
25
Increased
107
Reduced
61
Closed
11

Top Buys

Rank Stock Value
1
USG
Usg
USG
+$1.46M
2
FAST icon
Fastenal
FAST
+$1.28M
3
AMZN icon
Amazon
AMZN
+$1.09M
4
EFX icon
Equifax
EFX
+$930K
5
CHTR icon
Charter Communications
CHTR
+$900K

Top Sells

Rank Stock Value
1
BND icon
Vanguard Total Bond Market
BND
+$1.34M
2
SLB icon
SLB Ltd
SLB
+$806K
3
COR icon
Cencora
COR
+$725K
4
GILD icon
Gilead Sciences
GILD
+$724K
5
NEU icon
NewMarket
NEU
+$681K

Sector Composition

Rank Sector Weight
1 Financials 18.37%
2 Industrials 9.38%
3 Technology 9.36%
4 Healthcare 7.64%
5 Communication Services 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGM icon
151
MGM Resorts International
MGM
$11.7B
$529K 0.14%
+15,851
New +$511K
SHOP icon
152
Shopify
SHOP
$148B
$525K 0.14%
51,950
+2,400
+5% +$24.6K
IVV icon
153
iShares Core S&P 500 ETF
IVV
$869B
$515K 0.13%
+1,916
New +$502K
RHT
154
DELISTED
Red Hat Inc
RHT
$513K 0.13%
4,270
+2,030
+91% +$249K
BIIB icon
155
Biogen
BIIB
$29.9B
$506K 0.13%
1,589
+400
+34% +$128K
SCHX icon
156
Schwab US Large- Cap ETF
SCHX
$71B
$503K 0.13%
47,322
+2,760
+6% +$28.6K
IWR icon
157
iShares Russell Mid-Cap ETF
IWR
$56.8B
$498K 0.13%
9,564
CVS icon
158
CVS Health
CVS
$137B
$494K 0.13%
6,815
-290
-4% -$21.1K
MOAT icon
159
VanEck Morningstar Wide Moat ETF
MOAT
$11.5B
$485K 0.13%
11,430
BKK
160
DELISTED
Blackrock Municipal 2020 Term Trust
BKK
$473K 0.12%
+31,560
New +$483K
EWY icon
161
iShares MSCI South Korea ETF
EWY
$22.7B
$467K 0.12%
6,228
ABT icon
162
Abbott
ABT
$180B
$466K 0.12%
8,170
-100
-1% -$5.54K
LH icon
163
Labcorp
LH
$24.3B
$457K 0.12%
3,335
-145
-4% -$19.2K
ESRX
164
DELISTED
Express Scripts Holding Company
ESRX
$442K 0.11%
+5,924
New +$379K
ACN icon
165
Accenture
ACN
$89.9B
$439K 0.11%
2,870
+1,200
+72% +$174K
L icon
166
Loews
L
$24.3B
$437K 0.11%
+8,740
New +$432K
DEO icon
167
Diageo
DEO
$46.2B
$429K 0.11%
2,935
-63
-2% -$8.68K
FMS icon
168
Fresenius Medical Care
FMS
$13.2B
$420K 0.11%
7,992
-100
-1% -$4.97K
HEZU icon
169
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$565M
$413K 0.11%
13,840
BF.B icon
170
Brown-Forman Class B
BF.B
$12B
$403K 0.1%
9,180
WSM icon
171
Williams-Sonoma
WSM
$26.7B
$403K 0.1%
15,600
BWG
172
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$129M
$398K 0.1%
31,135
NUV icon
173
Nuveen Municipal Value Fund
NUV
$1.91B
$397K 0.1%
39,176
MCK icon
174
McKesson
MCK
$98.5B
$396K 0.1%
+2,540
New +$376K
TOL icon
175
Toll Brothers
TOL
$14B
$396K 0.1%
+8,250
New +$380K

Similar funds

Roundview Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Roundview Capital held 238 positions worth $387M, up 11% from $350M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Roundview Capital deployed $17.1M of net new capital in Q4 2017, opening 25 new positions and adding to 107 existing holdings. Its largest new stake was Equifax: 8,275 shares worth $976K.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $1.34M trimmed.

  • Roundview Capital's largest Q4 2017 buy was Equifax: 8,275 shares worth $976K.
  • Roundview Capital added most to Usg in Q4 2017, an estimated $1.46M increase.
  • Roundview Capital's biggest Q4 2017 reduction was Vanguard Total Bond Market, cutting an estimated $1.34M.
  • Roundview Capital fully exited Gilead Sciences in Q4 2017, selling an estimated $724K.
  • Roundview Capital's ten largest holdings make up 26% of its $387M portfolio in Q4 2017.
  • Roundview Capital opened 25 new positions and closed 11 in Q4 2017.
  • Roundview Capital's portfolio value rose 11% quarter-over-quarter to $387M.

Based on Roundview Capital's 13F filing for Q4 2017, filed 7 Feb 2018.